Preoperative combination therapy improves head and neck cancer outcomes

Preoperative combination therapy improves head and neck cancer outcomes

Patients with head and neck cancer who received chemotherapy in addition to immunotherapy before surgery had a significantly reduced tumor size at the time of operation than patients who received immunotherapy alone.

Preoperative Chemo-Immunotherapy More Effective Than Immunotherapy Alone in Patients With Head and Neck Cancer

Mount Sinai study shows tumors significantly reduced in patients who received dual approach before surgery